FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2940959893> ?p ?o ?g. }

• W2940959893 abstract "You have accessJournal of UrologyKidney Cancer: Epidemiology & Evaluation/Staging/Surveillance III (MP19)1 Apr 2019MP19-13 COMPARING UROLOGIST RECOMMENDATIONS FOR SMALL RENAL MASS BIOPSY WITH PATIENT OPINIONS BEFORE AND AFTER COUNSELING Tariq A. Khemees*, Anthony Bui, Daniel D. Shapiro, Sara L. Best, Shane A. Wells, Timothy J. Ziemlewicz, Meghan G. Lubner, James Louis Hinshaw, Fred T. Lee, David F. Jarrard, Kyle A. Richards, Tracy M. Downs, Stephen Y. Nakada, and E. Jason Abel Tariq A. Khemees*Tariq A. Khemees* More articles by this author , Anthony BuiAnthony Bui More articles by this author , Daniel D. ShapiroDaniel D. Shapiro More articles by this author , Sara L. BestSara L. Best More articles by this author , Shane A. WellsShane A. Wells More articles by this author , Timothy J. ZiemlewiczTimothy J. Ziemlewicz More articles by this author , Meghan G. LubnerMeghan G. Lubner More articles by this author , James Louis HinshawJames Louis Hinshaw More articles by this author , Fred T. LeeFred T. Lee More articles by this author , David F. JarrardDavid F. Jarrard More articles by this author , Kyle A. RichardsKyle A. Richards More articles by this author , Tracy M. DownsTracy M. Downs More articles by this author , Stephen Y. NakadaStephen Y. Nakada More articles by this author , and E. Jason AbelE. Jason Abel More articles by this author View All Author Informationhttps://doi.org/10.1097/01.JU.0000555502.48364.6dAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVES: Shared decision making is important for patients who are considering treatment of small renal masses (SRM). The purpose of this study was to compare patient's opinions with surgeon perspectives regarding the use of pre-treatment SRM biopsy. METHODS: A 5 question survey was given to 100 consecutive patients with SRM before and after treatment discussion. The patient survey contains questions about anxiety level (visual analog scale) and whether patients believed biopsy would be helpful make decision about treatment. In addition to patient survey, a 10 question surgeon survey was linked to email sent to active members of the Society of Urologic Oncology. Respondents were grouped based on date of completion of training, type of practice, and geographic location. RESULTS: A total of 100 consecutive patients completed a survey prior to discussion of SRM treatment. Pre-discussion anxiety was high with 46% of patients responding that SRM diagnosis was “among most stressful moments in life” When patients were asked “Would knowing whether or not there is cancer in your renal mass help you to make a decision about treatment?”, 81% answered yes. When asked if they would consider biopsy, 84% answered yes. After renal mass counseling, only 46% of patients answered yes to “did you decide to have a biopsy?”. A total of 42/100 patients subsequently received biopsy. Of 717 surgeons who were emailed, 111 (15.5%) completed the online survey. Practice type included: Academic (76%), private (18%) and military/government (6%). The median year when training was completed was 2009 (IQR 2000-2015) and 62% of respondents evaluating ≥5 SRM/month. When asked how often biopsy is recommended for SRM, 60% recommend biopsy <25% of SRM patients, 20% recommend biopsy for half of SRM patients and 20% recommend biopsy greater for than 75% of SRM. Training year and type of practice were not associated with how frequently biopsy was recommended (p=0.27, 0.17). Common responses for the advantage of using biopsy to evaluate SRM included: To identify benign tumors and avoid treatment (49%), to risk stratify renal cancer patients prior to treatment (21%), and to improve informed consent prior to treatment (14%). The most common response for why biopsy was not recommended is that it would not change management (86%). CONCLUSIONS: Before counseling, most SRM patients favor biopsy. After treatment discussion, less than half of patients favored biopsy with 42% subsequently receiving biopsy. Practice patterns remain variable among surgeons, with 40% of respondents recommending biopsy for at least half of SRM evaluated. Source of Funding: None Madison, WI© 2019 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 201Issue Supplement 4April 2019Page: e279-e279 Advertisement Copyright & Permissions© 2019 by American Urological Association Education and Research, Inc.MetricsAuthor Information Tariq A. Khemees* More articles by this author Anthony Bui More articles by this author Daniel D. Shapiro More articles by this author Sara L. Best More articles by this author Shane A. Wells More articles by this author Timothy J. Ziemlewicz More articles by this author Meghan G. Lubner More articles by this author James Louis Hinshaw More articles by this author Fred T. Lee More articles by this author David F. Jarrard More articles by this author Kyle A. Richards More articles by this author Tracy M. Downs More articles by this author Stephen Y. Nakada More articles by this author E. Jason Abel More articles by this author Expand All Advertisement PDF downloadLoading ..." @default.
• W2940959893 created "2019-05-03" @default.
• W2940959893 creator A5008376174 @default.
• W2940959893 creator A5012539326 @default.
• W2940959893 creator A5013098590 @default.
• W2940959893 creator A5021709456 @default.
• W2940959893 creator A5028100965 @default.
• W2940959893 creator A5029471486 @default.
• W2940959893 creator A5033987994 @default.
• W2940959893 creator A5048201634 @default.
• W2940959893 creator A5051002338 @default.
• W2940959893 creator A5073338534 @default.
• W2940959893 creator A5077067684 @default.
• W2940959893 creator A5081379122 @default.
• W2940959893 creator A5082486810 @default.
• W2940959893 creator A5086484037 @default.
• W2940959893 date "2019-04-01" @default.
• W2940959893 modified "2023-09-23" @default.
• W2940959893 title "MP19-13 COMPARING UROLOGIST RECOMMENDATIONS FOR SMALL RENAL MASS BIOPSY WITH PATIENT OPINIONS BEFORE AND AFTER COUNSELING" @default.
• W2940959893 doi "https://doi.org/10.1097/01.ju.0000555502.48364.6d" @default.
• W2940959893 hasPublicationYear "2019" @default.
• W2940959893 type Work @default.
• W2940959893 sameAs 2940959893 @default.
• W2940959893 citedByCount "0" @default.
• W2940959893 crossrefType "journal-article" @default.
• W2940959893 hasAuthorship W2940959893A5008376174 @default.
• W2940959893 hasAuthorship W2940959893A5012539326 @default.
• W2940959893 hasAuthorship W2940959893A5013098590 @default.
• W2940959893 hasAuthorship W2940959893A5021709456 @default.
• W2940959893 hasAuthorship W2940959893A5028100965 @default.
• W2940959893 hasAuthorship W2940959893A5029471486 @default.
• W2940959893 hasAuthorship W2940959893A5033987994 @default.
• W2940959893 hasAuthorship W2940959893A5048201634 @default.
• W2940959893 hasAuthorship W2940959893A5051002338 @default.
• W2940959893 hasAuthorship W2940959893A5073338534 @default.
• W2940959893 hasAuthorship W2940959893A5077067684 @default.
• W2940959893 hasAuthorship W2940959893A5081379122 @default.
• W2940959893 hasAuthorship W2940959893A5082486810 @default.
• W2940959893 hasAuthorship W2940959893A5086484037 @default.
• W2940959893 hasBestOaLocation W29409598931 @default.
• W2940959893 hasConcept C126322002 @default.
• W2940959893 hasConcept C161191863 @default.
• W2940959893 hasConcept C2780091579 @default.
• W2940959893 hasConcept C2780227381 @default.
• W2940959893 hasConcept C2992994880 @default.
• W2940959893 hasConcept C41008148 @default.
• W2940959893 hasConcept C61434518 @default.
• W2940959893 hasConcept C71924100 @default.
• W2940959893 hasConceptScore W2940959893C126322002 @default.
• W2940959893 hasConceptScore W2940959893C161191863 @default.
• W2940959893 hasConceptScore W2940959893C2780091579 @default.
• W2940959893 hasConceptScore W2940959893C2780227381 @default.
• W2940959893 hasConceptScore W2940959893C2992994880 @default.
• W2940959893 hasConceptScore W2940959893C41008148 @default.
• W2940959893 hasConceptScore W2940959893C61434518 @default.
• W2940959893 hasConceptScore W2940959893C71924100 @default.
• W2940959893 hasIssue "Supplement 4" @default.
• W2940959893 hasLocation W29409598931 @default.
• W2940959893 hasOpenAccess W2940959893 @default.
• W2940959893 hasPrimaryLocation W29409598931 @default.
• W2940959893 hasRelatedWork W1995557975 @default.
• W2940959893 hasRelatedWork W2019250753 @default.
• W2940959893 hasRelatedWork W2071494235 @default.
• W2940959893 hasRelatedWork W2102644969 @default.
• W2940959893 hasRelatedWork W2766770000 @default.
• W2940959893 hasRelatedWork W2770144974 @default.
• W2940959893 hasRelatedWork W2967287585 @default.
• W2940959893 hasRelatedWork W3208701539 @default.
• W2940959893 hasRelatedWork W4313346385 @default.
• W2940959893 hasRelatedWork W4317816533 @default.
• W2940959893 hasVolume "201" @default.
• W2940959893 isParatext "false" @default.
• W2940959893 isRetracted "false" @default.
• W2940959893 magId "2940959893" @default.
• W2940959893 workType "article" @default.